-
Mashup Score: 3Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback | Eiger BioPharmaceuticals - 1 year(s) ago
The Investor Relations website contains information about Eiger BioPharmaceuticals’s business for stockholders, potential investors, and financial analysts.
Source: Eiger BioPharmaceuticalsCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 19Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback | Eiger BioPharmaceuticals - 2 year(s) ago
The Investor Relations website contains information about Eiger BioPharmaceuticals’s business for stockholders, potential investors, and financial analysts.
Source: Eiger BioPharmaceuticalsCategories: Infectious Disease, Latest HeadlinesTweet
@PaulSaxMD @TogetherTrial @US_FDA The company released a press release on Oct 5 which explained their perspective on why the FDA rejected their request for a EUA pre-meeting request. https://t.co/kPVOWA9cLr